| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.26 | 1e-05 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |